Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Cytopenias”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)WithdrawnNCT00004114
What this trial is testing

Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00066599
What this trial is testing

Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy

Who this might be right for
Kidney CancerLeukemiaLymphoma+6 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT02948283
What this trial is testing

Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia

Who this might be right for
AnemiaFatigueFever+10 more
City of Hope Medical Center 3
Early research (Phase 1)Study completedNCT00003597
What this trial is testing

Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors

Who this might be right for
Cancer
Children's Oncology Group 16
Not applicableLooking for participantsNCT04800458
What this trial is testing

Contribution of Anti-platelet Antibodies Identified With MAIPA Assay in the Demonstration of the Auto-immune Character of a Thrombocytopenia at Diagnosis

Who this might be right for
ThrombocytopeniaImmune ThrombocytopeniaMyelodysplasia
University Hospital, Bordeaux 225
Testing effectiveness (Phase 2)Study completedNCT02148133
What this trial is testing

Assess the Safety and Efficacy of Eltrombopag in Japanese Subjects With Refractory, Moderate or More Severe Aplastic Anemia

Who this might be right for
Cytopaenia
Novartis Pharmaceuticals 21
Testing effectiveness (Phase 2)Looking for participantsNCT07175493
What this trial is testing

CM336 in Patients With Relapsed or Refractory Autoimmune Cytopenia

Who this might be right for
Autoimmune CytopeniaImmune Thrombocytopenia (ITP)Autoimmune Hemolytic Anemia+1 more
Keymed Biosciences Co.Ltd 158
Testing effectiveness (Phase 2)UnknownNCT05562882
What this trial is testing

A Clinical Trial to Assess Safety and Efficacy of Daratumumab in the Treatment of Primary Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China 60
Testing effectiveness (Phase 2)Study completedNCT03838354
What this trial is testing

A Clinical Trial of Chidamide in the Management of Refractory ITP

Who this might be right for
Thrombocytopenia
Shandong University 61
Early research (Phase 1)Study completedNCT00020371
What this trial is testing

BMS-247550 in Treating Patients With Cancers That Have Not Responded to Previous Therapy

Who this might be right for
Unspecified Adult Solid Tumor, Protocol SpecificNeutropenia
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00003675
What this trial is testing

Topotecan in Treating Patients With Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Alliance for Clinical Trials in Oncology 100
Early research (Phase 1)Ended earlyNCT00589316
What this trial is testing

Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation and Donor Bone Marrow Transplant in Treating Patients With Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or High-Risk Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+7 more
Fred Hutchinson Cancer Center
Large-scale testing (Phase 3)UnknownNCT00043134
What this trial is testing

Low-Dose Decitabine Compared With Standard Supportive Care in Treating Older Patients With Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
European Organisation for Research and Treatment of Cancer - EORTC 220
Early research (Phase 1)Study completedNCT06534255
What this trial is testing

A Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of MegaLT Injection for Treating Refractory Thrombocytopenia Following Radiotherapy, Chemotherapy, or Transplantation.

Who this might be right for
Refractory Thrombocytopenia
Anhui Provincial Hospital 10
Early research (Phase 1)Looking for participantsNCT07072247
What this trial is testing

RN1201 Injection in the Treatment of Antibody-Mediated Diseases

Who this might be right for
Refractory Immune-mediated Platelet Transfusion RefractorinessRelapsed or Refractory Immune Thrombocytopenia
The First Affiliated Hospital of Soochow University 9
Not applicableStudy completedNCT00682799
What this trial is testing

Serial Analysis of Chimerism in Patients With Refractory Cytopenia (RC) Transplanted With Reduced Intensity Conditioning (RIC)

Who this might be right for
Refractory Cytopenia of ChildhoodReduced Intensity Conditioning (RIC)Myelodysplastic Syndrome (MDS)+1 more
Charlotte Niemeyer, MD 112
Large-scale testing (Phase 3)Study completedNCT00003938
What this trial is testing

Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients

Who this might be right for
Cancer
European Organisation for Research and Treatment of Cancer - EORTC 115
Not applicableNot Yet RecruitingNCT07561385
What this trial is testing

Dresden MDS Registry With an Accompanying Biomaterial Collection

Who this might be right for
MDS (Myelodysplastic Syndrome)MDS/Myeloproliferative Neoplasm (MPN) Overlap SyndromeCHIP+1 more
Technische Universität Dresden 500
Testing effectiveness (Phase 2)Looking for participantsNCT05599880
What this trial is testing

The Investigate Efficacy and Safety Evaluation of Bortezomib in Patients With Relapsed/Refractory Immune Thrombocytopenia

Who this might be right for
Relapsed/Refractory Immune Thrombocytopenia
Seoul National University Hospital 29
Testing effectiveness (Phase 2)Study completedNCT01929980
What this trial is testing

Bortezomib to Treat Significant Complication of HSCT

Who this might be right for
Allogeneic Stem Cell TransplantationRefractory Autoimmune Cytopenia(s)
Children's Hospital Medical Center, Cincinnati 4
Next Page
26